OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Antiproliferative and palliative activity of flavonoids in colorectal cancer
Javier Fernández, Blanca Silván, Rodrigo Entrialgo‐Cadierno, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112241-112241
Open Access | Times Cited: 229

Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 106

Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects
Paola Di Nardo, C. Lisanti, Mattia Garutti, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 11, pp. 1341-1355
Open Access | Times Cited: 61

Pharmacologic Management of Persistent Pain in Cancer Survivors
Paul Glare, Karin R. Aubrey, Amitabh Gulati, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 275-291
Open Access | Times Cited: 37

Peripheral neuropathy associated with monomethyl auristatin E-based antibody-drug conjugates
Zhiwen Fu, Chen Gao, Ting Wu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107778-107778
Open Access | Times Cited: 14

Bortezomib-induced peripheral neuropathy in patients with multiple myeloma: pain syndrome and psychopathological aspects
Elmira Zalimkhanovna Irugova, Л. П. Менделеева, Д.Э. Выборных, et al.
Oncohematology (2025) Vol. 20, Iss. 1, pp. 154-164
Open Access

Diosgenin relieves oxaliplatin-induced pain by affecting TLR4/NF-κB inflammatory signaling and the gut microbiota
Shuli Man, Lu Xie, Xuanshuo Liu, et al.
Food & Function (2022) Vol. 14, Iss. 1, pp. 516-524
Closed Access | Times Cited: 15

Calcium signaling in chemotherapy-induced neuropathy
Matheus de Castro Fonseca, Paulo HS. Marazzi-Diniz, M. Fátima Leite, et al.
Cell Calcium (2023) Vol. 113, pp. 102762-102762
Closed Access | Times Cited: 8

Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy
Yang Li, Thomas Drabison, Mahesh R. Nepal, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 7

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
Natalia Mitin, Kirsten A. Nyrop, Susan L. Strum, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 12

Endoplasmic Reticulum Stress in Chemotherapy-Induced Peripheral Neuropathy: Emerging Role of Phytochemicals
Yugal Goel, Raghda Fouda, Kalpna Gupta
Antioxidants (2022) Vol. 11, Iss. 2, pp. 265-265
Open Access | Times Cited: 10

Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer
Rita Verhoeff-Jahja, Moniek M. ter Kuile, Nir I. Weijl, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 8, pp. 6947-6953
Open Access | Times Cited: 8

Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain
Ashley Takeshita, Bruce D. Hammock, Karen Wagner
Frontiers in Pain Research (2023) Vol. 3
Open Access | Times Cited: 4

Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway
Shih-Hung Wang, Shu‐Hung Huang, Meng‐Chien Willie Hsieh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5379-5379
Open Access | Times Cited: 4

Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO
Matthias Zaiß, Jens Uhlig, Mark‐Oliver Zahn, et al.
Oncology Research and Treatment (2021) Vol. 44, Iss. 11, pp. 613-621
Open Access | Times Cited: 8

Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma
С. В. Семочкин, M. V. Solovyev, Л. П. Менделеева
Oncohematology (2022) Vol. 17, Iss. 2, pp. 141-150
Open Access | Times Cited: 6

Neuromuscular complications of cancer therapy
Andreas A. Argyriou, Jordi Bruna, Elisa Mantovani, et al.
Current Opinion in Neurology (2021) Vol. 34, Iss. 5, pp. 658-668
Closed Access | Times Cited: 6

Chemotherapy-Induced Peripheral Neuropathy
Ashish Jain, Hariprasad MG, Mohammad Sharique, et al.
Indian Journal of Pharmaceutical Education and Research (2023) Vol. 57, Iss. 2, pp. 342-353
Open Access | Times Cited: 2

Potential Roles of 5-HT3 Receptor Antagonists in Reducing Chemotherapy-induced Peripheral Neuropathy (CIPN)
Raajeswari Satiamurthy, Nor Syafinaz Yaakob, Noraida Mohamed Shah, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 4, pp. 341-349
Closed Access | Times Cited: 4

Extremity Exercise Program in Breast Cancer Survivors Suffering from Chemotherapy-Induced Peripheral Neuropathy: A Feasibility Pilot Study
Chih‐Jung Wu, Ya‐Ning Chan, Li-Yu Yen, et al.
Healthcare (2022) Vol. 10, Iss. 4, pp. 688-688
Open Access | Times Cited: 3

The role of High-mobility group box-1 and Psoriasin in multiple myeloma: Analysis of a population affected by monoclonal gammopathies and review of the literature
Marco Casciaro, Donatella Vincelli, Maria Ferraro, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154562-154562
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top